Prevalence and Associated Factors of Anemia among Breast Cancer Patients Undergoing Chemotherapy: A Prospective Study

Table 4

Type of relationship between prevalence of anemia and demographic and clinical factors.

Variables	Prevalence of Anemia
	b	OR	CI (95%)		Value^a
			Lower	Upper
Age group
The Elderly ≤60 years	Reference
Young age > 60 years	2.015	7.5	3.062	18.388	≤0.001
BMI kg/m^2
Not obese (≤25)	Reference
Obese (>25)	2.5	12.4	4.55	34.07	≤0.001
Number of regimens
1	Reference
> 1	4.305	74.08	21.9	249.7	≤0.001
Dose reduction
Not detected	Reference
Reduced	0.414	1.514	1.514	.518	0.448
Not reduced	- 4.961	1.419	.007	.001	≤0.001
Chemotherapy type
Docetaxel received	Reference
Not received	-1.381	0.251	.092	.687	0.007

^aLogistic regression analysis.  < 0.05 indicates a level of significance. ^aFEC, fluorouracil, epirubicin, cyclophosphamide.